IBT Staff Reporter

80671-80700 (out of 154947)

Apple begins production of new iPad: report

Apple has begun to make a new version of its iPad tablet computer with a front-facing camera and faster processor, the Wall Street Journal reported, citing people familiar with the matter.

NYSE, Deutsche Boerse in advanced merger talks

Germany's Deutsche Boerse is in advanced talks to buy NYSE Euronext, and the London Stock Exchange has agreed to buy Canadian stock market operator TMX, as exchanges globally look for ways to boost their markets and cut costs.

Cuba unblocks access to controversial blog

Dissident blogger Yoani Sanchez said on Tuesday the Cuban government apparently has unblocked access to her blog, which had been off limits on the island's Internet since 2008.

America Movil sees mobile subs flagging in 2011

Billionaire Carlos Slim's America Movil, one of the world's biggest telecommunications firms, sees growth in new mobile subscribers slowing by around a third in 2011 due to the saturation of Latin America's markets.

Mercedes-Benz Fashion Week kicks off

It's the time of year again when all fashion enthusiasts come together for a week-long celebration of couture in New York. Mercedes-Benz Fall 2011 Fashion Week runs from Feb. 10 through Feb. 17.

Kate Middleton deemed top fashion buzzword

Prince William's bride-to-be, Kate Middleton, has de-throned Lady Gaga as the top fashion buzzword for the fashion season that starts in New York on Feb 10, according to a survey released on Tuesday.

Boeing CEO confident in new 787 delivery target

Boeing Co may have overextended the global supply chain on its long-overdue 787 Dreamliner program, but the company is confident it will meet its third-quarter delivery target, Chief Executive Jim McNerney said on Wednesday.

Sanofi says Genzyme takeover talks progressing

Sanofi-Aventis reported progress in talks to buy U.S. biotech Genzyme and predicted 5-10 percent lower earnings in 2011, underscoring the French drugmaker's need to find new sources of revenue growth.

Medtronic's MRI-safe pacemaker gets FDA nod

Medtronic Inc. (NYSE: MDT) said the U.S. Food and Drug Administration (FDA) approved its Revo MRI pacemaker - the first such device in the U.S. designed for safe use during certain magnetic resonance imaging (MRI) exams.

Pages